Aus den Archiven für Radiologische Pathologie^[1] – Tumoren der Dura: zur Differenzialdiagnose des Meningeoms – Korrelation zwischen radiologischen und pathologischen Befunden^[2]

Zusammenfassung

Der häufigste Tumor mit Durabeteiligung ist das Meningeom; bei der differenzialdiagnostischen Abklärung aller durabasierten Tumoren steht es daher immer an erster Stelle. Es gibt jedoch eine ganze Reihe anderer neoplastischer und nicht neoplastischer Läsionen, an denen die Dura ebenfalls beteiligt ist. Aus der Kenntnis der Anatomie der Dura lassen sich Hinweise auf die verschiedenen Prozesse gewinnen, die sich an dieser Lokalisation abspielen können. Bei den neoplastischen Prozessen handelt es sich teils um benigne, teils um maligne Läsionen: Hämangioperizytome, Lymphome, solitäre fibröse Tumoren, melanozytäre Läsionen, Epstein-Barr-Virus-assoziierte Tumoren der glatten Muskulatur, Manifestationen der Rosai-Dorfman-Krankheit und Metastasen. Als nicht neoplastische Prozesse sind infektiöse und entzündliche Entitäten, wie Tuberkulose und Sarkoidose, zu nennen, die Tumoren sehr ähnlich sein können. In manchen Fällen entwickeln sich Neoplasien, wie z. B. Gliosarkome, an der Peripherie des Hirnparenchyms, sodass der Anschein erweckt wird, sie gingen von der Dura aus und hätten sogar einen Duraausläufer (sog. Dural Tail). Viele dieser Läsionen weisen in der bildgebenden Darstellung mittels CT, MRT und Angiografie Gemeinsamkeiten mit den Meningeomen auf, z. B. einen Dural Tail, eine vermehrte Gefäßversorgung, prompte Kontrastmittelanreicherung und Ähnlichkeiten der Signalcharakteristika. Alter, Geschlecht und Grundkrankheiten des Patienten sowie bestimmte Besonderheiten im Bildgebungsbefund ermöglichen jedoch wichtige Rückschlüsse auf die Art der Läsionen. So sollte beispielsweise bei der Differenzialdiagnose durabasierter Läsionen bei HIV-infizierten Personen (Personen mit Infektion durch das humane Immundefizienzvirus) auch an die Epstein-Barr-Virus-assoziierten Tumoren der glatten Muskulatur gedacht werden. Das chirurgische Vorgehen bei den einzelnen Läsionen ist verschieden und ebenso die Prognose. Die Kenntnis der unterschiedlichen Läsionen, die die Dura betreffen, ihrer Bildgebungsbefunde und ihrer klinischen Merkmale hilft bei der Eingrenzung der radiologischen Differenzialdiagnose und bei der Optimierung der Therapie.

Abstract

Meningioma is the most common mass involving the dura, making it number one in the differential diagnosis for any dural-based mass; however, a variety of other neoplastic and nonneoplastic lesions also involve the dura. Knowledge of the dural anatomy can provide clues to the various processes that may involve this location. The neoplastic processes include both benign and malignant lesions such as hemangiopericytoma, lymphoma, solitary fibrous tumor, melanocytic lesions, Epstein-Barr virus-associated smooth muscle tumors, Rosai-Dorfman disease, and metastatic lesions. The nonneoplastic processes include infectious and inflammatory entities such as tuberculosis and sarcoid, which may mimic mass lesions. In some cases, neoplasms such as gliosarcoma may arise peripherally from the brain parenchyma, appearing dural-based and even inciting a dural tail. Many of these share similar computed tomographic, magnetic resonance imaging, and angiographic characteristics with meningiomas, such as a dural tail, increased vascularity, avid enhancement, and similar signal characteristics; however, knowledge of the patient’s age, gender, and underlying conditions and certain imaging characteristics may provide valuable clues to recognizing these lesions. For example, in the population with human immunodeficiency virus infection, Epstein-Barr virus-associated smooth muscle tumors should be included in the differential diagnosis for dural-based lesions. The surgical course and prognosis for these lesions vary, and knowledge of the variety of lesions that involve the dura, their imaging appearances, and their clinical features assists in narrowing the radiologic differential diagnosis and optimizing patient treatment.

¹ mit Unterstützung des American Institute for Radiologic Pathology (AIRP), des Joint Pathology Center (JPC) und der Uniformed Services University of the Health Sciences (USU)

^{2 ©} 2014 The Radiological Society of North America. All rights reserved. Originally puplished in English in RadioGraphics 2014; 34: 295 – 312. Online published in 10.1148 /rg.342130075. Translated and reprinted with permission of RSNA. RSNA is not responsible for any inaccuracy or error arising from the translation from English to German.

• Literatur

• 1 Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmerman’s pericytes. Ann Surg 1942; 116: 26-33
• 2 Giannini C, Rushing EJ, Hainfellner JA. Haemangiopericytoma. In: Louis DN, Ohagaki H, Wiestler OD, et al., eds. WHO classification of tumours of the central nervous system. Lyon, France: IARC; 2007: 178-180
• 3 Goellner JR, Laws Jr ER, Soule EH et al. Hemangiopericytoma of the meninges: Mayo Clinic experience. Am J Clin Pathol 1978; 70: 375-380
• 4 Bouvier C, Métellus P, de Paula AM et al. Solitary fibrous tumors and hemangiopericytomas of the meninges: overlapping pathological features and common prognostic factors suggest the same spectrum of tumors. Brain Pathol 2012; 22: 511-521
• 5 Perry A, Scheithauer BW, Nascimento AG. The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am J Surg Pathol 1997; 21: 1354-1360
• 6 Liu G, Chen ZY, Ma L et al. Intracranial hemangiopericytoma: MR imaging findings and diagnostic usefulness of minimum ADC values. J Magn Reson Imag 2013; 38: 1146-1151
• 7 Guthrie BL, Ebersold MJ, Scheithauer BW et al. Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery 1989; 25: 514-522
• 8 Barba I, Moreno A, Martinez-Pérez I et al. Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas. J Neurosurg 2001; 94: 55-60
• 9 Mena H, Ribas JL, Pezeshkpour GH et al. Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol 1991; 22: 84-91
• 10 Savage NM, Alleyne CH, Vender JR et al. Dural-based metastatic carcinomas mimicking primary CNS neoplasia: report of 7 cases emphasizing the role of timely surgery and accurate pathologic evaluation. Int J Clin Exp Pathol 2011; 4: 530-540
• 11 Abrahams JM, Forman MS, Lavi E et al. Hemangiopericytoma of the third ventricle: case report. J Neurosurg 1999; 90: 359-362
• 12 Fountas KN, Kapsalaki E, Kassam M et al. Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev 2006; 29: 145-153
• 13 Sibtain NA, Butt S, Connor SEJ. Imaging features of central nervous system haemangiopericytomas. Eur Radiol 2007; 17: 1685-1693
• 14 Zhou JL, Liu JL, Zhang J et al. Thirty-nine cases of intracranial hemangiopericytoma and anaplastic hemangiopericytoma: a retrospective review of MRI features and pathological findings. Eur J Radiol 2012; 81: 3504-3510
• 15 Zimmerman HM. Malignant lymphomas of the nervous system. Acta Neuropathol Suppl 1975; 6 (Suppl. 06) 69-74
• 16 Said R, Rizk S, Dai Q. Clinical challenges of primary diffuse large B-cell lymphoma of the dura: case report and literature review. ISRN Hematol 2011; 2011: 945212
• 17 Ferguson SD, Musleh W, Gurbuxani S et al. Intracranial mucosa-associated lymphoid tissue (MALT) lymphoma. J Clin Neurosci 2010; 17: 666-669
• 18 Kumar S, Kumar D, Kaldjian EP et al. Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma. Am J Surg Pathol 1997; 21: 81-87
• 19 Altundag MK, Ozişik Y, Yalcin S et al. Primary low grade B-cell lymphoma of the dura in an immunocompetent patient. J Exp Clin Cancer Res 2000; 19: 249-251
• 20 Venkataraman G, Rizzo KA, Chavez JJ et al. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol 2011; 24: 355-366
• 21 Lachance DH, O’Neill BP, Macdonald DR et al. Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology 1991; 41: 95-100
• 22 Narberhaus B, Buxó J, Pérez de Olaguer J et al. Primary dural lymphoma [in Spanish]. Neurologia 1996; 11: 117-119
• 23 Miranda RN, Glantz LK, Myint MA et al. Stage IE non-Hodgkin’s lymphoma involving the dura: a clinicopathologic study of five cases. Arch Pathol Lab Med 1996; 120: 254-260
• 24 Iwamoto FM, DeAngelis LM, Abrey LE. Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology 2006; 66: 1763-1765
• 25 Gocmen S, Gamsizkan M, Onguru O et al. Primary dural lymphoma mimicking a subdural hematoma. J Clin Neurosci 2010; 17: 380-382
• 26 Nayak L, Abrey LE, Iwamoto FM. Intracranial dural metastases. Cancer 2009; 115: 1947-1953
• 27 Kleinschmidt-DeMasters BK. Dural metastases: a retrospective surgical and autopsy series. Arch Pathol Lab Med 2001; 125: 880-887
• 28 Widdel L, Kleinschmidt-DeMasters BK, Kindt G. Tumor-to-tumor metastasis from hematopoietic neoplasms to meningiomas: report of two patients with significant cerebral edema. World Neurosurg 2010; 74: 165-171
• 29 Mawrin C, Perry A. Pathological classification and molecular genetics of meningiomas. J Neurooncol 2010; 99: 379-391
• 30 McKenzie CR, Rengachary SS, McGregor DH et al. Subdural hematoma associated with metastatic neoplasms. Neurosurgery 1990; 27: 619-624 ; discussion 624–625
• 31 Lui YW, Malhotra A, Farinhas JM et al. Dynamic perfusion MRI characteristics of dural metastases and meningiomas: a pilot study characterizing the first-pass wash-in phase beyond relative cerebral blood volume. AJR Am J Roentgenol 2011; 196: 886-890
• 32 Lou X, Chen ZY, Wang FL et al. MR findings of Rosai-Dorfman disease in sellar and suprasellar region. Eur J Radiol 2012; 81: 1231-1237
• 33 Resnick DK, Johnson BL, Lovely TJ. Rosai-Dorfman disease presenting with multiple orbital and intracranial masses. Acta Neuropathol (Berl.) 1996; 91: 554-557
• 34 Antuña Ramos A, Alvarez Vega MA, Alles JV et al. Multiple involvement of the central nervous system in Rosai-Dorfman disease. Pediatr Neurol 2012; 46: 54-56
• 35 Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder – analysis of 34 cases. Cancer 1972; 30: 1174-1188
• 36 Said R, Abi-Fadel F, Talwar J et al. Intracranial Rosai-Dorfman: a clinical challenge. Neurologist 2011; 17: 117-119
• 37 Mahzoni P, Zavareh MHI, Bagheri M et al. Intracranial Rosai-Dorfman disease. J Res Med Sci 2012; 17: 304-307
• 38 Mehraein Y, Wagner M, Remberger K et al. Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. J Clin Pathol 2006; 59: 1320-1326
• 39 Rodriguez-Galindo C, Helton KJ, Sánchez ND et al. Extranodal Rosai-Dorf­man disease in children. J Pediatr Hematol Oncol 2004; 26: 19-24
• 40 Raslan OA, Schellingerhout D, Fuller GN et al. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol 2011; 196: W187-W193
• 41 Zhu H, Qiu LH, Dou YF et al. Imaging characteristics of Rosai-Dorfman disease in the central nervous system. Eur J Radiol 2012; 81: 1265-1272
• 42 Huang HY, Huang CC, Lui CC et al. Isolated intracranial Rosai-Dorfman disease: case report and literature review. Pathol Int 1998; 48: 396-402
• 43 Clarençon F, Bonneville F, Rousseau A et al. Intracranial solitary fibrous tumor: imaging findings. Eur J Radiol 2011; 80: 387-394
• 44 Carneiro SS, Scheithauer BW, Nascimento AG et al. Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma – a clinicopathologic and immunohistochemical study. Am J Clin Pathol 1996; 106: 217-224
• 45 Johnson MD, Powell SZ, Boyer PJ et al. Dural lesions mimicking meningiomas. Hum Pathol 2002; 33: 1211-1226
• 46 Fargen KM, Opalach KJ, Wakefield D et al. The central nervous system solitary fibrous tumor: a review of clinical, imaging and pathologic findings among all reported cases from 1996 to 2010. Clin Neurol Neurosurg 2011; 113: 703-710
• 47 Bisceglia M, Galliani C, Giannatempo G et al. Solitary fibrous tumor of the central nervous system: a 15-year literature survey of 220 cases (August 1996 – July 2011). Adv Anat Pathol 2011; 18: 356-392
• 48 Mekni A, Kourda J, Hammouda KB et al. Solitary fibrous tumour of the central nervous system: pathological study of eight cases and review of the literature. Pathology 2009; 41: 649-654
• 49 Rutten I, Raket D, Francotte N et al. Contribution of NMR spectroscopy to the differential diagnosis of a recurrent cranial mass 7 years after irradiation for a pediatric ependymoma. Childs Nerv Syst 2006; 22: 1475-1478
• 50 Sivendran S, Vidal CI, Barginear MF. Primary intracranial leiomyosarcoma in an HIV-infected patient. Int J Clin Oncol 2011; 16: 63-66
• 51 Lerdlum S, Lalitanantpong S, Numkarunarunrote N et al. MR imaging of CNS leiomyosarcoma in AIDS patients. J Med Assoc Thai 2004; 87: S152-S160
• 52 Purgina B, Rao UN, Miettinen M et al. AIDS-related EBV-associated smooth muscle tumors: a review of 64 published cases. Pathol Res Int 2011; 2011: 561548
• 53 Zevgaridis D, Tsonidis C, Kapranos N et al. Epstein-Barr virus associated primary intracranial leiomyoma in organ transplant recipient: case report and review of the literature. Acta Neurochir (Wien) 2009; 151: 1705-1709
• 54 Bejjani GK, Stopak B, Schwartz A et al. Primary dural leiomyosarcoma in a patient infected with human immunodeficiency virus: case report. Neurosurgery 1999; 44: 199-202
• 55 Smith AB, Rushing EJ, Smirniotopoulos JG. Pigmented lesions of the central nervous system: radiologic-pathologic correlation. RadioGraphics 2009; 29: 1503-1524
• 56 Jellinger K, Böck F, Brenner H. Meningeal melanocytoma: report of a case and review of the literature. Acta Neurochir (Wien) 1988; 94: 78-87
• 57 Rades D, Heidenreich F, Tatagiba M et al. Therapeutic options for meningeal melanocytoma: case report. J Neurosurg 2001; 95: 225-231
• 58 Painter TJ, Chaljub G, Sethi R et al. Intracranial and intraspinal meningeal melanocytosis. AJNR Am J Neuroradiol 2000; 21: 1349-1353
• 59 Takeuchi T, Sato M, Sonomura T et al. Erdheim-Chester disease associated with intramedullary spinal cord lesion. Br J Radiol 2012; 85: e62-e64
• 60 Lachenal F, Cotton F, Desmurs-Clavel H et al. Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol 2006; 253: 1267-1277
• 61 Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996; 75: 157-169
• 62 Sedrak P, Ketonen L, Hou P et al. Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease. AJNR Am J Neuroradiol 2011; 32: 2126-2131
• 63 Drier A, Haroche J, Savatovsky J et al. Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology 2010; 255: 586-594
• 64 Alfieri A, Gazzeri R, Galarza M et al. Surgical treatment of intracranial Erdheim-Chester disease. J Clin Neurosci 2010; 17: 1489-1492
• 65 Martinez R. Erdheim-Chester disease: MR of intraaxial and extraaxial brain stem lesions. AJNR Am J Neuroradiol 1995; 16: 1787-1790
• 66 Christoforidis GA, Spickler EM, Recio MV et al. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol 1999; 20: 655-669
• 67 Shah R, Roberson GH, Curé JK. Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis. AJNR Am J Neuroradiol 2009; 30: 953-961
• 68 Rybicki BA, Major M, Popovich Jr J et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241
• 69 Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol 2001; 248: 363-372
• 70 Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol 2004; 182: 289-295
• 71 Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM 2009; 102: 449-460